Coral Laboratories Ltd
₹0.00▲ +0.00 (+0.00%)
524506·NSE·Healthcare
Market Cap
205.24 Cr
PE Ratio
12.40
Volume
—
Day High - Low
—
52W High-Low
659.00 - 360.00
₹0.00▲ +0.00 (+0.00%)
Market Cap205.24 Cr
PE Ratio12.40
Volume—
Day High - Low—
52W High-Low659.00 - 360.00
Coral Laboratories Ltd (524506): company summary
Coral Laboratories Ltd (524506) is a micro-cap Healthcare company valued at ₹205 crore operating in Pharmaceuticals on the NSE and BSE.
Coral Laboratories Ltd (524506) is a micro-cap Healthcare company valued at ₹205 crore operating in Pharmaceuticals on the NSE and BSE.
- Financial performance
- Revenue has been growing slowly at 3.3% a year over three years; profit grew 42.4% a year, ahead of revenue — margins are expanding. Return on equity is 7.9%.
- Valuation multiples
- The stock trades at 12.4 times earnings, a discount to the Healthcare median of 32.5, 0.97 times book value. It yields 0.3%.
Generated from DocStoX data. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
Not currently trading — we have seen no trades on NSE or BSE recently. It may be suspended, delisted, or renamed after a corporate action. Not a live price.
DocStoX Score
5.1/10
Weak
Fair Value
Sign in to see
ROE
7.88%
Weak
P/E
12.40x
Cheap
Debt / Equity
0.02
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Weak
Price performance
52W₹360.00
₹659.00
DocStoX take
Supported by valuation (7.3), but held back by growth (2.4). Scored on 4 of 5 measures.
DocStoX score
Medium confidence5.1
/10
Weak
Quality
Solid
ROE 7.9%
Valuation
Fair
P/E 12.4×
Growth
Flat
Revenue -2.4% 5Y CAGR
Risk
Elevated
D/E 0.02
Momentum
No data
No technical indicators
Scored on 4 of 5 measures — the rest have no data for this company.
At a glance
Market Cap
₹205 Cr
52W High / Low
₹659 / ₹360
Dividend Yield
0.26%
Promoter Holding
71.51%
EPS (TTM)
₹67.63
Book Value
₹585.74
Key highlights
- Low leverage — D/E 0.02
- Profitable in all of the last 5 years
- Undemanding at 12× earnings
- Revenue shrinking 2% a year
- Growth is weak (2.4/10)
4 Positives3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Coral Laboratories Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Coral Laboratories Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
SUN PHARMACEUTICAL IND LDIVI S LABORATORIES LTDTORRENT PHARMACEUTICALS LAPOLLO HOSPITALS ENTER. LZYDUS LIFESCIENCES LTDCIPLA LTDLAURUS LABS LIMITEDMAX HEALTHCARE INS LTDAUROBINDO PHARMA LTDDR. REDDY S LABORATORIESLUPIN LIMITEDMANKIND PHARMA LIMITED
Compare Coral Laboratories Ltd with peers
Related tools & concepts
Value Coral Laboratories Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing